Skip to main content
The power to target muscle to
stop or reverse disease progression
Myotonic logo
Learn more about Dyne’s commitment to people living with serious muscle diseases Watch Video >

Scientific Publications & Presentations

October 11–15, 2022
Building a FORCE platform-based DMD franchise for the treatment of individuals with mutations amenable to exon skipping Presented at the 27th International Hybrid Annual Congress of the World Muscle Society
May 14, 2021